Skip to main content
DexCom Inc.
Healthcare · Medical Devices
Made on Aug 26, 2026
Price at call $88.96
6-month call Bear -10.1%
Target by Feb 2027 $80.00
Great value below $65.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -10.1% to $80.00
Predicted High $89.50 in 2 weeks
Predicted Low $80.00 at 6 months
Max Drawdown (predicted) -10.1%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 26, 2026 1:10 pm
Bear DXCM trends lower to $80.00 (-10.1% from $88.96) by Feb 2027. decay
ThesisDXCM trades far above composite fair value with a fading platform-monopoly narrative and Abbott competitive pressure weighing on sentiment, but recent momentum (21.6% trailing 6mo) and a risk-on regime cushion near-term downside. Path drifts sideways-to-lower as valuation gravity slowly reasserts, roughly tracking the deterministic baseline.
Invalidated ifA decisive break above 100 on positive CGM share data or a break below 75 on Abbott share gains would falsify the slow-drift thesis.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $88.96 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 26, 2026 $88.96 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 9, 2026 $81.25–$96.67 typical range · internal point $89.50 ±8.7% 6/10 Risk-on regime and momentum support near-term drift
What actually happened: closed $84.53 on Sep 8, 2026 = -5.0% vs the call (predicted +0.6%)  ·  direction HIT (called flat, was flat)  ·  off by 5.6 pp  ·  accuracy 8/10  ·  typical range ±8.7%: inside the band  ·  S&P 0.0% over the same window — lagged it
1 month Sep 26, 2026 $77.79–$100.13 typical range · internal point $88.00 ±12.6% 6/10 Sentiment headwind begins to offset momentum
2 months Oct 26, 2026 $85.50 -3.9% 5/10 Competitive drumbeat pressures multiple modestly
3 months Nov 26, 2026 $83.00 -6.7% 5/10 Value gravity toward anchored-PE 88 fades lower
4 months Dec 26, 2026 $82.00 -7.8% 4/10 Year-end positioning, no catalyst to reverse trend
5 months Jan 26, 2027 $81.00 -8.9% 4/10 Pre-earnings drift as fair-value pull continues
6 months Feb 26, 2027 $80.00 -10.1% 4/10 Converges near deterministic baseline endpoint

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $80.11 (-9.9%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$88.96
Composite fair value$39.98
Signal-adjusted fair value$49.32
DCF fair value$29.00
Anchored-PE fair value$88.60
Buy-below (value lens)$65.00
Value net score-51
Value confidence6 / 10
Quality net score+68
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 49.1%  3m 43.5%  6m 41.4%  
Daily σ (realism noise)2.7%
Beta vs S&P 500 1m 0.90  3m 0.53  5m 0.63  
Trailing 6-month return21.6%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 26, 2026 freshest DXCM-20260826-010001-9388
ext-forensic-memo Aug 26, 2026 freshest ext-DXCM-20260826-012429-df5b
ext-lens-quality Aug 26, 2026 freshest ext-DXCM-20260826-012429-df5b
ext-lens-sentiment Aug 26, 2026 freshest ext-DXCM-20260826-012429-df5b
ext-lens-value Aug 26, 2026 freshest ext-DXCM-20260826-012429-df5b
scenario-valuation Aug 26, 2026 freshest DXCM-20260826-010001-9388
valuation-synthesis Aug 26, 2026 freshest DXCM-20260826-010001-9388

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 27, 2026 v0.6.0 Bear $90.07 $79.00 -12.3% Feb 2027 view
Aug 26, 2026 v0.6.0 Bear $88.96 $80.00 -10.1% Feb 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.